MARCH5 promotes aerobic glycolysis to facilitate ovarian cancer progression via ubiquitinating MPC1
Apoptosis · 2024
DOI: 10.1007/s10495-024-01962-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Apoptosis, 2024. Verfasst von Ying Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology and Obstetrics, Xijing Hospital, Air Force Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Glycolysis, Ovarian Neoplasms, Ubiquitin-Protein Ligases, Ubiquitination. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Basic Research Plan in Shaanxi Province of China, Key R&D plan of Shaanxi Province, The National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
MARCH5 is a ring-finger E3 ubiquitin ligase located in the outer membrane of mitochondria. A previous study has reported that MARCH5 was up-regulated and contributed to the migration and invasion of OC cells by serving as a competing endogenous RNA. However, as a mitochondrial localized E3 ubiquitin ligase, the function of MARCH5 in mitochondrial-associated metabolism reprogramming in human cancers remains largely unexplored, including OC. We first assessed the glycolysis effect of MARCH5 in OC both in vitro and in vivo. Then we analyzed the effect of MARCH5 knockdown or overexpression on respiratory activity by evaluating oxygen consumption rate, activities of OXPHOS complexes and production of ATP in OC cells with MARCH5. Co-immunoprecipitation, western-blot, and in vitro and vivo experiments were performed to investigate the molecular mechanisms underlying MARCH5-enhanced aerobic glycolysis s in OC. In this study, we demonstrate that the abnormal upregulation of MARCH5 is accompanied by significantly increased aerobic glycolysis in OC. Mechanistically, MARCH5 promotes aerobic glycolysis via ubiquitinating and degrading mitochondrial pyruvate carrier 1 (MPC1), which mediates the transport of cytosolic pyruvate into mitochondria by localizing on mitochondria outer membrane. In line with this, MPC1 expression is significantly decreased and its downregulation is closely correlated with unfavorable survival. Furthermore, in vitro and in vivo assays revealed that MARCH5 upregulation-enhanced aerobic glycolysis played a critical role in the proliferation and metastasis of OC cells. Taken together, we identify a MARCH5-regulated aerobic glycolysis mechanism by degradation of MPC1, and provide a rationale for therapeutic targeting of aerobic glycolysis via MARCH5-MPC1 axis inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynaecology and Obstetrics, Xijing Hospital, Air Force Medical University, Xi'an, China.
- Department of Gynaecology and Obstetrics, Xijing Hospital, Air Force Medical University, Xi'an, China. lijia219@yeah.net.
- Department of Gynaecology and Obstetrics, Xijing Hospital, Air Force Medical University, Xi'an, China. yanghongfck@163.com.
Förderung
- Natural Science Basic Research Plan in Shaanxi Province of China
- Key R&D plan of Shaanxi Province
- The National Natural Science Foundation of China (NSFC)
- Health Scientific Research Innovation Ability Improvement Plan in Shaanxi Province of China
Zitieren
APA
Xu, Y., Zhao, S., Shen, Y., Li, Y., Dang, Y., Guo, F., Chen, Z., Li, J., & Yang, H. (2024). MARCH5 promotes aerobic glycolysis to facilitate ovarian cancer progression via ubiquitinating MPC1. Apoptosis. https://doi.org/10.1007/s10495-024-01962-5
Vancouver
Xu Y, Zhao S, Shen Y, Li Y, Dang Y, Guo F, et al. MARCH5 promotes aerobic glycolysis to facilitate ovarian cancer progression via ubiquitinating MPC1. Apoptosis. 2024. doi:10.1007/s10495-024-01962-5
BibTeX
@article{Xu2024,
author = {Xu, Ying and Zhao, Shuhua and Shen, Yujie and Li, Yuanfeng and Dang, Yinghui and Guo, Fenfen and Chen, Zhihao and Li, Jia and Yang, Hong},
title = {MARCH5 promotes aerobic glycolysis to facilitate ovarian cancer progression via ubiquitinating MPC1},
journal = {Apoptosis},
year = {2024},
doi = {10.1007/s10495-024-01962-5}
}
EUVIMED